StemBioSys Inc. announced today that it will add a second office location. StemBioSys’s new location in Houston will be located in Johnson & Johnson Innovation, JLABS (JLABS) at the Texas Medical Center (JLABS @ TMC). JLABS is a life science innovation center, providing a flexible environment for start-up companies pursuing new technologies and research platforms to advance medical care.
StemBioSys Inc. announced today that it has entered into an agreement with SeouLin Bioscience to distribute and market StemBioSys products in The Republic of Korea (South Korea).
StemBioSys Inc. announced today that it has licensed additional technology from UT Health™ San Antonio that expands the company’s intellectual property portfolio aimed at enabling the expansion of adult stem cells for therapeutic use.
GenCure, a subsidiary of San Antonio-based biotech BioBridge Global, has entered a development and manufacturing agreement with stem cell technology developer StemBioSys Inc. of San Antonio.
StemBioSys Inc. announced today that it has entered into an agreement with VWR (NASDAQ: VWR) to distribute and market StemBioSys products. VWR, the leading global independent provider of product and service solutions to laboratory and production facilities, will be the exclusive distributor for StemBioSys in both the United States and Canada.